James A. Geraghty, Director at IDERA PHARMACEUTICALS, INC. (IDRA), bought 10,000 shares at $5.58 ($56K) on 2018-08-07, disclosed to the SEC on 2018-08-08.
Open-market purchase of $56k IDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| VYGR | BUY | 2018-08-21 | $110K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |
| PIRS | BUY | 2017-08-17 | $48K | — | Filing → |